Cover Image
市場調查報告書

Griffin Discoveries BV的產品平台分析

Griffin Discoveries BV - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 321357
出版日期 內容資訊 英文 23 Pages
訂單完成後即時交付
價格
Back to Top
Griffin Discoveries BV的產品平台分析 Griffin Discoveries BV - Product Pipeline Review - 2015
出版日期: 2015年07月15日 內容資訊: 英文 23 Pages
簡介

Griffin Discoveries BV是開發G蛋白偶聯受體 (GPCR) 為目標的小分子醫藥品的藥物研發企業。

本報告提供Griffin Discoveries BV 的治療藥開發平台的現狀及各開發階段比較分析、藥物標的、作用機制、各分子類型的治療藥的評估等。

Griffin Discoveries BV的基本資料

Griffin Discoveries BV概要

  • 主要資訊
  • 企業資料

Griffin Discoveries BV:R&D概要

  • 主要的治療範圍

Griffin Discoveries BV:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Griffin Discoveries BV:開發中產品概況

  • 初期階段的開發中產品
    • 在前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Griffin Discoveries BV:藥物簡介

  • GD-134
  • GD-48
  • 前庭障礙的拮抗組織胺H4受體的小分子
  • 眼科疾病及氣喘的拮抗組織胺H1/H受體的小分子

Griffin Discoveries BV:開發平台分析

  • 各標的
  • 各分子類型
  • 各作用機制

Griffin Discoveries BV:總公司和子公司的所在地

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07320CDB

Summary

Global Markets Direct's, 'Griffin Discoveries BV - Product Pipeline Review - 2015', provides an overview of the Griffin Discoveries BV's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Griffin Discoveries BV's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Griffin Discoveries BV including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Griffin Discoveries BV's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Griffin Discoveries BV's pipeline products

Reasons to buy

  • Evaluate Griffin Discoveries BV's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Griffin Discoveries BV in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Griffin Discoveries BV's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Griffin Discoveries BV and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Griffin Discoveries BV
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Griffin Discoveries BV and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Griffin Discoveries BV Snapshot
    • Griffin Discoveries BV Overview
    • Key Information
    • Key Facts
  • Griffin Discoveries BV - Research and Development Overview
    • Key Therapeutic Areas
  • Griffin Discoveries BV - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Griffin Discoveries BV - Pipeline Products Glance
    • Griffin Discoveries BV - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Griffin Discoveries BV - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Griffin Discoveries BV - Drug Profiles
    • Small Molecules to Antagonize Histamine H4 Receptor for Vestibular Disorders
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • GD-134
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • GD-136
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • GD-48
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Antagonize Histamine H1/H4 Receptor for Ophthalmology and Asthma
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Griffin Discoveries BV - Pipeline Analysis
  • Griffin Discoveries BV - Pipeline Products by Target
  • Griffin Discoveries BV - Pipeline Products by Molecule Type
  • Griffin Discoveries BV - Pipeline Products by Mechanism of Action
  • Griffin Discoveries BV - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Griffin Discoveries BV, Key Information
  • Griffin Discoveries BV, Key Facts
  • Griffin Discoveries BV - Pipeline by Indication, 2015
  • Griffin Discoveries BV - Pipeline by Stage of Development, 2015
  • Griffin Discoveries BV - Monotherapy Products in Pipeline, 2015
  • Griffin Discoveries BV - Phase I, 2015
  • Griffin Discoveries BV - Preclinical, 2015
  • Griffin Discoveries BV - Discovery, 2015
  • Griffin Discoveries BV - Pipeline by Target, 2015
  • Griffin Discoveries BV - Pipeline by Molecule Type, 2015
  • Griffin Discoveries BV - Pipeline Products by Mechanism of Action, 2015

List of Figures

  • Griffin Discoveries BV - Pipeline by Top 10 Indication, 2015
  • Griffin Discoveries BV - Pipeline by Stage of Development, 2015
  • Griffin Discoveries BV - Monotherapy Products in Pipeline, 2015
  • Griffin Discoveries BV - Pipeline by Top 10 Target, 2015
  • Griffin Discoveries BV - Pipeline by Top 10 Molecule Type, 2015
  • Griffin Discoveries BV - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top